The progression and severity of GvHD was evaluated by recording the weight loss, which is representative of the health of the mouse, GvHD score [18], survival, proportion of human CD45+ lymphocyte infiltration, and histopathology fibrotic scoring in the lung (Ashcroft) and liver (Ishak). Here, PTPRC is linked to graft versus host disease.